Dr. Yuki Yoshimatsu at Tochigi Cancer Center, Japan
Dr. Yuki Yoshimatsu is a leading cancer biologist and Project Leader at the Tochigi Cancer Center Research Institute, Japan. She holds a Ph.D. in Medical Science from the University of Tokyo and has extensive experience in rare cancer research, particularly sarcomas. Her career includes senior roles at the National Cancer Center Research Institute in Tokyo and postdoctoral training at the University of Washington, USA. Her research focuses on patient-derived cancer models, drug sensitivity screening, kinomic profiling, and biomarker discovery for precision oncology. She has established over 100 rare cancer models and contributed to national clinical guidelines. Dr. Yoshimatsu is also committed to mentoring young female scientists and advancing translational oncology through international collaboration.
Professional Profile:
ORCID
Summary of Suitability for Women Researcher Award: Dr. Yuki Yoshimatsu
Dr. Yuki Yoshimatsu exemplifies excellence in biomedical research and leadership in translational oncology, making her a highly deserving candidate for the Women Researcher Award. With a Ph.D. in Medical Science from the University of Tokyo and extensive research experience at prestigious institutions including the National Cancer Center Japan and the University of Washington, Dr. Yoshimatsu has established herself as a leading figure in rare cancer biology.
🎓 Education
Ph.D. in Medical Science
🏛️ University of Tokyo, Graduate School of Medicine
🧬 Department of Pathology
📍 Tokyo, Japan
💼 Professional Experience
Project Leader
🏥 Tochigi Cancer Center Research Institute
📍 Tochigi, Japan | ⏳ 2022 – Present
🔬 Leading translational research in rare cancers and biomarker development
Senior Researcher
🧪 National Cancer Center Research Institute
📍 Tokyo, Japan | ⏳ 2016 – 2022
🧫 Established multiple patient-derived sarcoma models and conducted drug sensitivity profiling
Postdoctoral Fellow
🧬 University of Washington, Dept. of Otolaryngology
📍 Seattle, WA, USA | ⏳ 2012 – 2016
🌎 International research in viral oncogenesis and multi-step carcinogenesis
🧪 Research Interests
🧫 Rare cancers (esp. sarcomas)
🧬 Patient-derived cancer models (cell lines, organoids, xenografts)
💊 Drug sensitivity screening & kinomic profiling
🧠 Biomarker discovery for precision oncology
🦠 Viral oncogenesis & multi-step carcinogenesis
🏆 Honors & Awards
🥇 Best Presentation Award
“Establishment and characterization of a novel leiomyosarcoma cell line”
📅 Aug 2023 | 🧬 Japanese Society of Human Cell Science
🏅 Poster Award
“Construction of patient-derived sarcoma models”
📅 Nov 2021 | 🔬 Japan Society for Patient-Derived Cancer Models
🌍 International Research Grant
“Mechanisms of multi-step carcinogenesis in cervical cancer”
📅 Mar 2010 | 🧪 Kanzawa Medical Research Promotion Foundation
Publication Top Notes
Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1